Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on (S) NBHP. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN118126972A reveals acid-resistant carbonyl reductase mutant for efficient (S)-NBHP synthesis, offering significant cost reduction and supply chain reliability.
Patent CN118126972A reveals enhanced enzyme mutant for (S)-NBHP production offering superior acid resistance and reduced processing costs for pharmaceutical supply chains.
Patent CN110777125B details a novel Y127W mutant enzyme for high-concentration synthesis of chiral piperidine intermediates, offering significant cost reduction in API manufacturing.